Anti-inflammatory and anticancer effects of flavonol glycosides from Diplotaxis harra through GSK3β regulation in intestinal cells

References

• Antunes-Ricardo M, Moreno-García BE, Gutiérrez-Uribe JA, Aráiz-Hernández D, Alvarez MM, Serna-Saldivar SO. 2014. Induction of apoptosis in colon cancer cells treated with isorhamnetin glycosides from Opuntia ficus-indica pads. Plant Foods Hum Nutr. 69:331–336.
   PubMed Web of Science ®Google Scholar
• Atta EM, Hashem AI, Ahmed AM, Elqosy SM, Jasparse M, El-Sharkaw ER. 2011. Phytochemical studies on Diplotaxis harra growing in Sinai. Eur J Chem. 2:535–538.
   Google Scholar
• Bellakhdar J. 1997. La pharmacopée marocaine traditionnelle: médecine arabe ancienne et savoirs populaires. Paris: Ibis Press.
   Google Scholar
• Bourogaa E, Despeaux M, Jarraya R, Fabre N, Bertrand J, Payrastre L, Demur C, Damak M, Fournié J, El Feki A, et al. 2011 . Hammada scoparia flavonoids and rutin kill adherent and chemoresistant leukemic cells. Leuk Res. 35:1093–1101.
   PubMed Web of Science ®Google Scholar
• Dinkova-Kostova AT. 2012. Chemoprotection against cancer by isothiocyanates: a focus on the animal models and the protective mechanisms. Top Curr Chem. 329:179–201.
   Web of Science ®Google Scholar
• Falleh H, Msilini N, Oueslati S, Ksouri R, Magne C, Lachaal M, Karray-Bouraoui N. 2013. Diplotaxis harra and Diplotaxis simplex organs: assessment of phenolics and biological activities before and after fractionation. Ind Crops Prod. 45:141–147.
   Web of Science ®Google Scholar
• Fasano A, Fiorentini C, Donelli G, Uzzau S, Kaper JB, Margaretten K, Ding Z, Guandalini S, Comstock L, Goldblum SE. 1995. Zonula Occludens Toxin (ZOT) modulates tight junctions through protein kinase C-dependent actin reorganization, in vitro. J Clin Invest. 96:710–720.
   PubMed Web of Science ®Google Scholar
• Fini L, Piazzi G, Daoud Y, Selgrad M, Maegawa S, Garcia M, Fogliano V, Romano M, Graziani G, Vitaglione P, et al. 2011. Chemoprevention of intestinal polyps in ApcMin/+ mice fed with western or balanced diets by drinking Annurca apple polyphenol extract. Cancer Prev Res (Phila). 4:907–915.
   PubMed Web of Science ®Google Scholar
• Ghrabi Z. 2005. A guide to medicinal plants in North Africa. Malaga, Spain: IUCN Center for Mediterranean Cooperation.
   Google Scholar
• Grassilli E, Narloch R, Federzoni E, Ianzano L, Pisano F, Giovannoni R, Romano G, Masiero L, Leone BE, Bonin S, et al. 2013. Inhibition of GSK3B bypass drug resistance of p53-null colon carcinomas by enabling necroptosis in response to chemotherapy. Clin Cancer Res. 19:3820–3831.
   PubMed Web of Science ®Google Scholar
• Hoensch H, Groh B, Edler L, Kirch W. 2008. Prospective cohort comparison of flavonoid treatment in patients with resected colorectal cancer to prevent recurrence. World J Gastroenterol. 14:2187–2193.
   PubMed Web of Science ®Google Scholar
• Igarashi K, Mikami T, Takahashiy, Sato H. 2008. Comparison of the preventive activity of isorhamnetin glycosides from atsumi-kabu (Red Turnip, Brassica, campestris L.) leaves on carbon tetrachloride-induced liver injury in mice. Biosci Biotechnol Biochem. 72:856–860.
   PubMed Web of Science ®Google Scholar
• Johnson JL, Rupasinghe SG, Stefani F, Schuler MA, Gonzalez de Mejia E. 2011. Citrus flavonoids luteolin, apigenin, and quercetin inhibit glycogen synthase kinase-3β enzymatic activity by lowering the interaction energy within the binding cavity. J Med Food. 14:325–333.
   PubMed Web of Science ®Google Scholar
• Kassem ME, Afifi MS, Marzouk MM, Mostafa MA. 2013. Two new flavonol glycosides and biological activities of Diplotaxis harra (Forssk.) Boiss. Nat Prod Res. 27:2272–2280.
   PubMed Web of Science ®Google Scholar
• Kwon KH, Murakami A, Tanaka T, Ohigashi H. 2005. Dietary rutin, but not its aglycone quercetin, ameliorates dextran sulfate sodium-induced experimental colitis in mice: attenuation of pro-inflammatory gene expression. Biochem Pharmacol. 69:395–406.
   PubMed Web of Science ®Google Scholar
• Li S, Guan J, Ge M, Huang P, Lin Y, Gan X. 2015. Intestinal mucosal injury induced by tryptase-activated protease-activated receptor 2 requires β-arrestin-2 in vitro. Mol Med Rep. 12:7181–7187.
   PubMed Web of Science ®Google Scholar
• Liu H, Mou Y, Zhao J, Wang J, Zhou L, Wang M, Wang D, Han J, Yu Z, Yang F. 2010. Flavonoids from Halostachys caspica and their antimicrobial and antioxidant activities. Molecules. 15:7933–7945.
   PubMed Web of Science ®Google Scholar
• Mai W, Kawakami K, Shakoori A, Kyo S, Miyashita K, Yokoi K, Jin M, Shimasaki T, Motoo Y, Minamoto T. 2009. Deregulated GSK3βsustains gastrointestinal cancer cells survival by modulating human telomerase reverse transcriptase and telomerase. Clin Cancer Res. 15:6810–6819.
   PubMed Web of Science ®Google Scholar
• Mohammed MMD, El-Sharkawy ER, Matloub AA. 2013. Cytotoxic flavonoids from Diplotaxis harra (Forssk.) Boiss. growing in Sinai. J Med Plants Res. 7:19–23.
   Google Scholar
• Nasri I, Bonnet D, Zwarycz B, D’Aldebert E, Khou S, Mezghani-Jarraya R, Quaranta M, Rolland C, Bonnart C, Mas E, et al. 2016 . PAR2-dependent activation of GSK3β regulates the survival of colon stem/progenitor cells. Am J Physiol Gastrointest Liver Physiol. 311:G221–G236.
   PubMed Web of Science ®Google Scholar
• Neuman MG, Nanau RM. 2012. Inflammatory bowel disease: role of diet, microbiota, life style. Transl Res. 160:29–44.
   PubMed Web of Science ®Google Scholar
• Noda S, Tanabe S, Suzuki T. 2013. Naringenin enhances intestinal barrier function through the expression and cytoskeletal association of tight junction proteins in Caco-2 cells. Mol Nutr Food Res. 57:2019–2028.
   PubMed Web of Science ®Google Scholar
• Pan MH, Lai CS, Wu JC, Ho CT. 2011. Molecular mechanisms for chemoprevention of colorectal cancer by natural dietary compounds. Mol Nutr Food Res. 55:32–45.
   PubMed Web of Science ®Google Scholar
• Ramadan MF, Amer MMA, Mansour HT, Wahdan KM, El-Sayed RM, El-Sanhoty S, El-Gleel WA. 2009. Bioactive lipids and antioxidant properties of wild Egyptian Pulicaria incise, Diplotaxis harra, and Avicennia marina. J Verbr Lebensm. 4:239–245.
   Google Scholar
• Rossi M, Rosato V, Bosetti C, Lagiou P, Parpinel M, Bertuccio P, Negri E, Vecchia CL. 2010. Flavonoids, proanthocyanidins, and the risk of stomach cancer. Cancer Causes Control. 21:1597–1604.
   PubMed Web of Science ®Google Scholar
• Severson EA, Kwon M, Hilgarth RS, Parkos CA, Nusrat A. 2010. Glycogen Synthase Kinase 3 (GSK-3) influences epithelial barrier function by regulating occludin, claudin-1 and E-cadherin expression. Biochem Biophys Res Commun. 397:592–597.
   PubMed Web of Science ®Google Scholar
• Shakoori A, Mai W, Miyashita K, Yasumoto K, Takahashi Y, Ooi A, Kawakami K, Minamoto T. 2007. Inhibition of GSK-3 beta activity attenuates proliferation of human colon cancer cells in rodents. Cancer Sci. 98:1388–1393.
   PubMed Web of Science ®Google Scholar
• Steinbrecher KA, Wilson WIII, Cogswell PC, Baldwin AS. 2005. Glycogen synthase kinase 3beta functions to specify gene-specific, NF-kappaB-dependent transcription. Mol Cell Biol. 25:8444–8455.
   PubMed Web of Science ®Google Scholar
• Triantafillidis JK, Nasioulas G, Kosmidis PA. 2009. Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies. Anticancer Res. 29:2727–2738.
   PubMed Web of Science ®Google Scholar
• Tsuchiya K, Nakamura T, Okamoto R, Kanai T, Watanabe M. 2007. Reciprocal targeting of Hath1 and beta-catenin by Wnt glycogen synthase kinase 3beta in human colon cancer. Gastroenterology. 132:208–220.
   PubMed Web of Science ®Google Scholar
• Vermeulen L, Snippert HJ. 2014. Stem cell dynamics in homeostasis and cancer of the intestine. Nat Rev Cancer. 14:468–480.
   PubMed Web of Science ®Google Scholar
• Vinothkumar R, Vinoth Kumar R, Sudha M, Viswanathan P, Balasubramanian T, Nalini N. 2014. Modulatory effect of troxerutin on biotransforming enzymes and preneoplasic lesions induced by 1,2-dimethylhydrazine in rat colon carcinogenesis. Exp Mol Pathol. 96:15–26.
   PubMed Web of Science ®Google Scholar
• Wang HL, Hart J, Fan L, Mustafi R, Bissonnette M. 2011. Upregulation of glycogen synthase kinase 3β in human colorectal adenocarcinomas correlates with accumulation of CTNNB1. Clin Colorectal Cancer. 10:30–36.
   PubMed Web of Science ®Google Scholar
• Wang Q, Zhou Y, Evers BM. 2006. Neurotensin phosphorylates GSK-3alpha/beta through the activation of PKC in human colon cancer cells. Neoplasia. 8:781–787.
   PubMed Web of Science ®Google Scholar
• Whittle BJ, Varga C, Posa A, Molnar A, Collin M, Thiemermann C. 2006. Reduction of experimental colitis in the rat by inhibitors of glycogen synthase kinase-3beta. Br J Pharmacol. 147:575–582.
   PubMed Web of Science ®Google Scholar